Halozyme Therapeutics, Inc (HALO) Covered Calls

Halozyme Therapeutics, Inc covered calls Halozyme Therapeutics, Inc. is a biopharmaceutical company, which is dedicated to the development and commercialization of products targeting the extracellular matrix, or Matrix, for the endocrinology, oncology, dermatology and drug delivery markets.

You can sell covered calls on Halozyme Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for HALO (prices last updated Thu 4:16 PM ET):

Halozyme Therapeutics, Inc (HALO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
16.21 +0.04 13.35 17.50 579K 48 2.3B
Covered Calls For Halozyme Therapeutics, Inc (HALO)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
May 17 16 0.60 16.90 -5.3% -84.1%
Jun 21 16 1.00 16.50 -3.0% -18.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Halozyme Therapeutics, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel oncology therapies that target the tumor microenvironment. Its investigational drug PEGPH20, applies a unique approach to targeting solid tumors, allowing increased access of co-administered cancer drug therapies to the tumor. PEGPH20 is currently in development for metastatic pancreatic cancer and non-small cell lung cancer and has potential across additional cancers in combination with different types of cancer therapies. Halozyme Therapeutics was founded by Gregory Ian Frost in 1998 and is headquartered in San Diego, CA.